Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 17/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.81 |
| ▸ | MC5R | P33032 | 1/20 | 0.41 |
| ▸ | MC3R | P41968 | 1/20 | 0.41 |
| ▸ | SYK | P43405 | 2/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.37 |
| ▸ | BTK | Q06187 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31421661 | 1.00 | MC4R (1.00) | MC4RKCNH2MC5RMC3RSYK | |
| SCHEMBL25275069 | 0.96 | MC4R (0.92) | MC4RKCNH2MC5RMC3RSYK | |
| SCHEMBL30457859 | 0.96 | MC4R (0.92) | MC4RKCNH2MC5RMC3RSYK | |
| SCHEMBL25227906 | 0.96 | MC4R (0.92) | MC4RKCNH2MC5RMC3RSYK | |
| SCHEMBL31666916 | 0.95 | MC4R (0.91) | MC4RKCNH2MC5RMC3RSYK | |
| SCHEMBL31421679 | 0.93 | MC4R (0.86) | MC4RKCNH2SYK | |
| SCHEMBL25421666 | 0.90 | MC4R (1.00) | MC4RKCNH2MC5RMC3REGFR | |
| SCHEMBL30996495 | 0.90 | MC4R (1.00) | MC4RKCNH2MC5RMC3REGFR | |
| SCHEMBL31666900 | 0.88 | MC4R (0.79) | MC4RKCNH2SYK | |
| SCHEMBL31687307 | 0.87 | MC4R (1.00) | MC4RKCNH2MC5RMC3RSYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023105387-A1 | MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF | PFIZER INC. (US) | 2023-06-15 | — | — | WO | claimed |
| WO-2023105387-A1 | MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF | PFIZER INC. (US) | 2023-06-15 | — | — | WO | disclosed |